CLINICAL RESEARCH: MYOCARDIAL INFARCTION
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction
Seyyare Beyzade, BSc*,
Shaoli Zhang, PhD*,
Yuk-ki Wong, MD, MRCP ,
Ian N. M. Day, MB, PhD, FRCPath*,
Per Eriksson, PhD and
Shu Ye, MD, PhD*,*
* Human Genetics Division, Southampton University Medical School, Southampton, United Kingdom
Cardiothoracic Unit, Southampton General Hospital, Southampton, United Kingdom
Atherosclerosis Research Unit, Karolinska Hospital, Stockholm, Sweden
Manuscript received November 1, 2002;
revised manuscript received February 7, 2003,
accepted March 20, 2003.
* Reprint requests and correspondence: Dr. Shu Ye, Human Genetics Division, Southampton University Medical School, Duthie Building (808), Southampton General Hospital, Southampton SO16 6YD, United Kingdom.
Shu.Ye{at}soton.ac.uk
OBJECTIVES: The aim of this study was to assess matrix metallloproteinase-3 (MMP3) gene variation in relation to the degree of coronary atherosclerosis and risk of myocardial infarction (MI) in patients with coronary artery disease.
METHODS: In this study, we systematically screened the promoter and coding regions for sequence variants. All polymorphisms identified were analyzed in 1,240 individuals undergoing coronary angiography. Functional analyses of the polymorphisms were carried out with the use of report assays and electrophoretic mobility shift assays.
RESULTS: Six novel polymorphisms were identified. The 6A/6A genotype was associated with greater number of coronary arteries with significant stenosis (odds ratio [OR] 1.52, p = 0.008), whereas the 5A/5A and 5A/6A genotypes were associated with increased risk of MI (OR 2.02 and 1.78, p = 0.016 and 0.032, respectively). A stepwise logistic regression analysis with all polymorphisms taken into account showed that the effect of MI susceptibility was largely attributed to the 5A/6A polymorphism. In a stepwise logistic regression analysis with all haplotypes as independent variables, the most common haplotype (T-5A-A-A-G-A), and two rare haplotypes, all containing the 5A allele, were associated with MI susceptibility. Functional studies showed that the T-5A-A-A-G-A haplotype had a higher promoter activity in macrophages.
CONCLUSIONS: These data indicate that the effect of MMP3 gene variation is attributable to the 5A/6A polymorphism and that individuals carrying the 6A/6A genotype may be predisposed to developing atherosclerotic plaques with significant stenosis, whereas those carrying the 5A allele may be predisposed to developing unstable plaques.
|
Abbreviations and Acronyms
| | apo | = apolipoprotein | | CAD | = coronary artery disease | | bi-ddF | = bi-directional dideoxy fingerprinting | | MI | = myocardial infarction | | MMP | = matrix metalloproteinase | | PCR | = polymerase chain reaction |
|
This article has been cited by other articles:
|
|
|
|
 
Z. Mallat
Matrix Metalloproteinase-8 and the Regulation of Blood Pressure, Vascular Inflammation, and Atherosclerotic Lesion Growth
Circ. Res.,
October 23, 2009;
105(9):
827 - 829.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S M Raleigh, L van der Merwe, W J Ribbans, R K W Smith, M P Schwellnus, and M Collins
Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene
Br. J. Sports Med.,
July 1, 2009;
43(7):
514 - 520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. F. Hall, C. R. Gale, S. Ye, and C. N. Martyn
Myopia and Polymorphisms in Genes for Matrix Metalloproteinases
Invest. Ophthalmol. Vis. Sci.,
June 1, 2009;
50(6):
2632 - 2636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J.,
February 1, 2009;
30(3):
266 - 277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. V. Cockle, N. Gopichandran, J. J. Walker, M. I. Levene, and N. M. Orsi
Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications
Reproductive Sciences,
October 1, 2007;
14(7):
629 - 645.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Oceandy, R. Yusoff, F. M. Baudoin, L. Neyses, and S. G. Ray
Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients
Eur J Heart Fail,
October 1, 2007;
9(10):
1010 - 1017.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. White, S. J. Duffy, A. S. Walton, J. F. Ng, G. E. Rice, S. Mukherjee, J. A. Shaw, G. L. Jennings, A. M. Dart, and B. A. Kingwell
Matrix metalloproteinase-3 and coronary remodelling: Implications for unstable coronary disease
Cardiovasc Res,
September 1, 2007;
75(4):
813 - 820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Barlic and P. M. Murphy
Chemokine regulation of atherosclerosis
J. Leukoc. Biol.,
August 1, 2007;
82(2):
226 - 236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. G. Pearce, R. C. Laxton, A. C. Pereira, and S. Ye
Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells
Mol. Cancer Res.,
March 1, 2007;
5(3):
221 - 227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Abilleira, S. Bevan, and H. S Markus
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis
J. Med. Genet.,
December 1, 2006;
43(12):
897 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Traurig, P. A. Permana, S. Nair, S. Kobes, C. Bogardus, and L. J. Baier
Differential Expression of Matrix Metalloproteinase 3 (MMP3) in Preadipocytes/Stromal Vascular Cells From Nonobese Nondiabetic Versus Obese Nondiabetic Pima Indians
Diabetes,
November 1, 2006;
55(11):
3160 - 3165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ye
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
Cardiovasc Res,
February 15, 2006;
69(3):
636 - 645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Newby and J. L. Johnson
Genetic Strategies to Elucidate the Roles of Matrix Metalloproteinases in Atherosclerotic Plaque Growth and Stability
Circ. Res.,
November 11, 2005;
97(10):
958 - 960.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Johnson, S. J. George, A. C. Newby, and C. L. Jackson
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
PNAS,
October 25, 2005;
102(43):
15575 - 15580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Flex, E. Gaetani, P. Papaleo, G. Straface, A. S. Proia, G. Pecorini, P. Tondi, P. Pola, and R. Pola
Proinflammatory Genetic Profiles in Subjects With History of Ischemic Stroke
Stroke,
October 1, 2004;
35(10):
2270 - 2275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S L F Pender, P J P Croucher, S Mascheretti, J D Prothero, S A Fisher, T T MacDonald, S Schreiber, and S. Ye
Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease
J. Med. Genet.,
September 1, 2004;
41(9):
e112 - e112.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Blons, S. Gad, F. Zinzindohoue, I. Maniere, J. Beauregard, D. Tregouet, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig
Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res.,
April 15, 2004;
10(8):
2594 - 2599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
